University of Oxford Psychiatry PhD (DPhil): How Do Hormones Shape Belief Updating Across Reproductive Transitions?

University of Oxford Psychiatry PhD (DPhil): How Do Hormones Shape Belief Updating Across Reproductive Transitions?

Quick Decision

This Oxford DPhil would test whether hormone-related changes across menstrual-cycle phases and around menopause affect belief updating in psychosis. The proposed design combines repeated comparisons, clinical assessment, cognitive tasks, hormone measures, continuous EEG and computational models. Key methods remain unspecified, including sample size, reproductive-stage criteria, hormone sampling, task/model, EEG outcomes and recruitment.

Funding requires written confirmation before the place can be treated as fully funded. The project description names a Wolfson Marriott award and at least £22,460 per year, but the saved Wolfson information says Marriott criteria remain under review and lists a separate Psychiatry/Clarendon scholarship. The scholarship deadline (27 November) and expected interview week (14 December) also differ from the DPhil deadline (1 December) and usual January interviews. Confirm award status, overseas-fee liability and applicable dates with the department and Wolfson College.

Research Problem and Doctoral Work

What Is Unsolved and Why It Matters

The project asks whether hormonal transitions change the way the brain weighs prior beliefs against incoming sensory information, and whether this process helps explain variation in psychosis symptoms. The question links two active but not yet fully connected research areas: hormone-related variation in psychosis vulnerability and computational accounts of belief updating. Recent reviews discuss psychosis risk around menstrual and menopausal transitions, but they also identify gaps in direct measurement of menopause stage and ovarian hormones. A 2024 Finnish register study of 3,488 women with schizophrenia-spectrum disorders found that menopausal hormone therapy use was associated with a lower risk of psychosis relapse in some age bands. That observational treatment study does not show that hormones cause a particular pattern of belief updating, nor does it test EEG or the proposed cognitive task. Review of estrogen and psychosis, review of midlife psychosis risk, Brand et al. 2024 MHT study

Computational studies suggest that psychosis can involve altered ways of integrating new evidence with prior beliefs, but the results depend on the task and model. A 2025 study combined a predictive-inference task, computational modelling and fMRI in 19 people with psychosis-spectrum disorders and 40 controls; only five clinical participants were women, and the study did not measure hormonal variation. A separate 2025 paper tested a hierarchical Bayesian model across repeated healthy-volunteer sessions, a large online sample and a schizophrenia cohort. These studies make the proposed bridge plausible while leaving the central hormone-by-belief-updating question open. Fromm et al. 2025, computational phenotyping study

Work, Methods, and Potential Outputs

The project description proposes a set of linked comparisons and measurements:

1. Compare belief updating within participants across menstrual-cycle phases. The advertisement also proposes comparisons between premenopausal and postmenopausal participants, including people with schizophrenia-spectrum conditions and healthy controls. It does not give a sample size, diagnostic threshold, cycle-phase definition or menopause-staging method.
2. Measure brain activity with continuous EEG. The project description does not identify the EEG system, task timing, acquisition schedule, signal features or analysis pipeline. “Continuous EEG” should be read as continuous recording during the relevant task/session unless the research team confirms a broader monitoring design.
3. Fit computational models of learning and decision-making. The aim is to quantify how participants balance prior expectations against new sensory evidence. The specific task, model family, parameter-identification plan and relationship between model parameters and clinical outcomes are not stated.
4. Measure hormones, cognition and clinical symptoms. Hormone assays, sampling times, symptom instruments, medication variables and rules for contraceptive use or hormone therapy are not specified. These details matter because an age or calendar-day label alone may not represent an individual's hormone state.

Menstrual-cycle research guidance recommends defining the biological question first and characterizing reproductive status and cycle phase with appropriate within-person measurements. Calendar-day counting alone can misclassify phases because cycle length and ovulation vary. Ask whether the study will use hormone assays, ovulation confirmation or another validated phase method, and how it will handle irregular cycles and hormonal contraception. Menopause comparisons also need a stated staging rule. Practical menstrual-cycle methods guide

The design crosses repeated cycle measurements with reproductive stage and psychosis/control groups. That can be scientifically valuable but requires enough participants in each cell, repeated data per participant, and a plan for factors such as age, medication, prolactin, sleep and cognitive performance. The current project description does not provide power calculations, cohort sizes, recruitment sites or a preregistered analysis plan. EEG and model outputs would be correlates of task performance; they would not by themselves establish a clinical mechanism or diagnostic test.

School, Programme and Field Context

The degree-awarding institution is the University of Oxford, through its DPhil in Psychiatry in the Department of Psychiatry. The course brings together clinical psychiatry, neuroscience, psychology, clinical trials, computational psychiatry and AI, data science, epidemiology, neuroimaging and psychopharmacology. Full-time study normally takes three to four years; part-time study takes six to eight years and still requires Oxford attendance. DPhil training includes advanced research methods, statistics, communication and professional development. Oxford DPhil in Psychiatry, Department of Psychiatry graduate context

Oxford reports first place globally in the 2025 Times Higher Education Medical and Health subject ranking. This is a broad university-level signal, not a psychiatry-specific ranking or evidence about this project's supervision. The course page lists about 18 full-time places and a three-year average of 147 applications per year for entry from 2024-25 to 2026-27; this indicates a competitive admissions context, not an individual probability of admission. Oxford's 2025 THE subject-ranking announcement

Oxford Psychiatry's research environment includes OPERA, which connects psychosis research across neuroscience, clinical studies and treatment, and the Oxford Centre for Human Brain Activity. The centre and Oxford Centre for Integrative Neuroimaging list EEG, MEG, MRI and other facilities. The current IN-PULSE study is a relevant local precedent: it uses EEG and cognitive tasks to examine hormones and psychosis vulnerability. These pages show nearby expertise and facilities, not guaranteed access, project priority or an existing patient cohort for this DPhil. The exact college membership and any formal college-based award also depend on the admissions/funding outcome. Oxford Psychiatry research groups, OPERA, Oxford Centre for Human Brain Activity, Oxford Centre for Integrative Neuroimaging: OHBA facilities, IN-PULSE study

Current Oxford information confirms the DPhil course and scholarship context, but does not confirm the full project plan or approval of a project-specific Marriott award. Treat the course and college pages as evidence about the DPhil and current scholarship context, not as confirmation that the described Marriott package has been approved for this project.

Supervisor and Lab Assessment

The project description names Rob McCutcheon, Laurence Hunt and Bodyl Brand. Their public profiles suggest complementary areas: McCutcheon studies psychosis and clinical treatment research; Hunt works on cognitive computational neuroscience and mathematical modelling of decisions; Brand focuses on women's mental health, psychosis and hormonal transitions. Brand leads the related IN-PULSE study. The public profiles do not confirm the formal supervisory team, how work will be divided, or who will provide day-to-day EEG, hormone-assay and clinical-recruitment support. McCutcheon profile, Hunt profile, Brand profile

Three recent research outputs help place the project:

• Brand et al., 2026, “Women and psychosis: a guide to evidence-based, hormone-informed care.” This review coauthored by Brand and McCutcheon synthesizes clinical questions across reproductive stages. It supports the importance of hormone-aware psychosis research while distinguishing evidence from clinical hypotheses. Full text in Oxford Research Archive
• Beck et al., 2026, “New approaches to clinical research for people with schizophrenia.” McCutcheon coauthored this review, which argues for representative recruitment and multidomain assessment in schizophrenia trials. It is relevant to cohort design but does not specify this project's recruitment protocol. PubMed record
• Brand et al., 2024, menopausal hormone therapy and relapse. In a Finnish within-subject register study, MHT use among 3,488 women with schizophrenia-spectrum disorders was associated with lower relapse risk overall, with differences by age at use. The observational findings motivate questions about hormones and symptoms; they do not establish that hormone levels alter belief updating or guarantee clinical benefit. Study

Other close field precedents include the 2025 belief-updating/fMRI study and an Oxford-linked 2025 electronic-health-record letter that attempted to identify rare menstrual-psychosis cases. The former used a small clinical sample with few women; the latter illustrates that reproductive-stage psychosis is difficult to define and identify in routine records. Fromm et al. 2025, Reilly et al. 2025

Funding, Application, and Living Cost

Funding status and fee exposure

The project description names a Wolfson Marriott Graduate Scholarship, says Home-rate course fees are covered, gives a UKRI stipend of at least £22,460 per year, and mentions research/conference support; it says an overseas fee difference would be self-funded. The current Wolfson page does not confirm that package. It lists a separate Wolfson College Psychiatry Scholarship, offered with Clarendon for 2027-28 and open to DPhil Psychiatry applicants with a preference for psychosis research; it describes course fees and living-cost support up to the UKRI minimum stipend of £21,805 for 2026-27. The same page says Marriott award criteria remain under review, with further details expected by the end of November 2026. Its 2027-28 Psychiatry scholarship particulars were due on 4 November 2026, one day after this research check. The existence, name, selection route, amount, duration and fee coverage of the project-specific Marriott award therefore need written confirmation. Wolfson College scholarships, UKRI training-grant-holder guidance

The official Oxford course page lists 2027-28 annual fees of £10,940 for Home students and £36,260 for Overseas students, a difference of £25,320 per year before future fee increases. If the project award covers only the Home rate, that difference is material. The project description says the international difference is self-funded; the current Wolfson page does not state whether its new Psychiatry scholarship pays Home or Overseas fees. Do not assume the gap is covered without an award letter. Oxford DPhil course fees and costs

UKRI's current minimum stipend is £21,805 for 2026-27. This is a published current-year rate, not a confirmed 2027-28 amount. The advertised £22,460 may be a future or enhanced amount, but the current official pages do not establish its basis. The project description's research/conference allowance and duration are also not independently specified on the current Wolfson page. Confirm the award letter's annual stipend, fee status, funding duration, conference/research budget and any international supplement before relying on it.

Deadlines and application requirements

The project description states a scholarship deadline of 12:00 noon UK time on Friday 27 November 2026, earlier than the Oxford DPhil course deadline of 12:00 noon UK time on Tuesday 1 December 2026. It expects interviews in the week beginning 14 December 2026. Oxford's current course page says DPhil interviews are normally online and typically held in January. These may be different funding and admissions stages, but no current official page explains the discrepancy. Confirm which date applies to the project and scholarship, whether the interview is a separate first-stage selection, and when references must arrive. Oxford DPhil deadline and admissions process

For the DPhil course, applicants need a relevant first-class or strong upper-second-class undergraduate degree; a prior master's is not required. Related research or work experience may help, and publications are not required. The course's standard English requirement includes IELTS Academic 7.0 overall with at least 6.5 per component. The project description separately calls independent research experience and quantitative programming important; EEG, computational modelling and clinical experience are desirable, not stated as separate formal course thresholds. The course application requires three referees, at least two academic, official transcripts, a combined statement of purpose (maximum 500 words) and research proposal (maximum 1,000 words). The online form captures CV information, and Oxford says not to upload a separate CV. The proposal is assessed for clarity, originality, methodological quality and feasibility. Oxford DPhil entry and application requirements

Living costs and purchasing power

Oxford estimates full-time living costs at £1,475-£2,175 per month for 2027-28. The current 2026-27 UKRI minimum stipend of £21,805 averages about £1,817 per month over twelve months. That falls within the published range but leaves about £358 per month between the stipend average and the upper estimate. This is only an arithmetic comparison: it does not confirm the 2027-28 stipend or payment schedule and excludes fee gaps, visa and immigration-health charges, travel, dependants and one-off arrival costs. Oxford DPhil living-cost estimate, UKRI stipend table

Applicant Fit and Preparation

Required background and skills

The formal course minimum is a first or strong upper-second-class degree in a relevant discipline; applicants do not need a master's degree. The project description separately emphasizes independent research experience and quantitative programming. It does not name a required programming language, a required clinical qualification or mandatory prior EEG experience.

Preferred experience and suggested preparation

The advertisement presents EEG, computational modelling and clinical experience as desirable. Applicants can prepare examples of quantitative research, reproducible coding and careful interpretation of uncertain clinical evidence. Familiarity with within-person designs, model comparison, psychosis research or hormone measurement could help explain interest, but these are not published additional eligibility requirements. A useful proposal or interview discussion would show how cycle/menopause status, hormone measures, cognitive task performance and clinical symptoms could be aligned without assuming that any one measure directly explains another.

The course describes destinations across academia, healthcare, pharmaceutical and biotechnology industries, health technology/data science, government, policy and scientific communication. NHS workforce plans identify growth in psychological professions and clinical-academic work. NIHR's Maudsley BRC has offered a separate preparatory research fellowship route for certain UK-registered health professionals; the cited 2026 intake is closed. These are adjacent routes rather than a job guarantee; a DPhil in Psychiatry does not by itself qualify someone as a clinician or regulated healthcare professional. Oxford DPhil graduate destinations, NHS Long Term Workforce Plan, NIHR Maudsley preparatory clinical research fellowships

Career Paths and Market Context

Possible routes include academic or postdoctoral research in psychosis and reproductive mental health, clinical trials and translational research, pharmaceutical or biotechnology R&D, health technology, health-data and computational work, and work in policy, research funding or science communication. Oxford’s graduate-destination information describes broad routes across academia, healthcare, industry, policy, health technology and data science; the NHS workforce plan discusses growth in psychological-profession training and clinical-academic roles. These sources indicate adjacent pathways, not vacancies or outcomes for this DPhil. NIHR Maudsley preparatory fellowships are a separate route with professional-registration and current-employment eligibility; this DPhil would not itself confer clinical registration. Oxford graduate destinations · NHS Long Term Workforce Plan · NIHR Maudsley preparatory fellowships

Next Actions and Questions to Verify

Before applying

• Ask Oxford Psychiatry and Wolfson College whether the Wolfson Marriott award is confirmed for this exact project or whether the relevant route is the separate Wolfson College Psychiatry Scholarship with Clarendon. Request the written 2027-28 award particulars, eligible fee status, stipend, duration, conference/research support and any overseas fee supplement.
• Confirm whether the binding scholarship deadline is 27 November at noon or the DPhil course deadline of 1 December at noon. Ask whether the advertised 14 December interview is a separate scholarship stage, given Oxford's usual January DPhil interviews.
• Confirm whether all three references and project-specific funding materials must be submitted by the earlier scholarship cutoff, and how the proposed project should appear in the 500-word statement and 1,000-word proposal.

At interview

• What are the planned sample sizes and clinical inclusion criteria for the psychosis-spectrum and healthy-control groups? How will the study handle diagnosis, symptom severity, age, medication, prolactin and comorbidities?
• Which menstrual phases and menopause stages are compared, and how are phase and hormone state verified? Which hormones are assayed, at what times, and how are irregular cycles, hormonal contraception and hormone therapy handled?
• What cognitive task and computational model will define belief updating? How will model parameters be validated, compared and tested for identifiability and test-retest reliability?
• What does “continuous EEG” mean for the session design? Which equipment, preprocessing pipeline and neural features are planned, and how will EEG measures be linked to model parameters and clinical outcomes?
• How are the three advertised supervisors and other clinical/statistical staff expected to divide supervision? Is the current IN-PULSE study separate, a source of methods experience, or connected to this project in any formal way?

Before accepting an offer

• Obtain a written funding award and budget showing fee status, any overseas fee difference, 2027-28 stipend, duration, research/conference funds and the terms if the award changes or is withdrawn.
• Confirm the DPhil college, registration and start arrangements; project recruitment sites; ethics and data-governance timetable; reserved EEG access; hormone-assay costs; and what happens if recruitment or repeated cycle visits take longer than expected.

Evidence and Sources

University, DPhil, funding and careers

• Oxford DPhil in Psychiatry: course, admissions, fees and living costs
• Department of Psychiatry: graduate environment
• Oxford 2025 THE Medical and Health subject ranking
• Wolfson College scholarships
• UKRI guidance for training grant holders
• NHS Long Term Workforce Plan
• NIHR Maudsley preparatory clinical research fellowships

Department, supervisors and research environment

• Oxford Psychiatry research groups
• OPERA: Oxford Psychosis Research & Application
• Robert McCutcheon profile
• Laurence Hunt profile
• Bodyl Brand profile
• IN-PULSE study
• Oxford Centre for Human Brain Activity
• OxCIN OHBA facilities

Research on psychosis, hormones and belief updating

• Brand et al. 2026, hormone-informed psychosis care guide
• Brand and Sommer 2026, women's mental health editorial
• Beck et al. 2026, clinical research in schizophrenia
• Fromm et al. 2025, uncertainty processing and belief updating in psychosis
• Computational phenotyping of aberrant belief updating
• All-or-nothing belief updating in schizophrenia
• Computational mechanisms of belief updating and psychotic-like experiences
• Reilly et al. 2025, identifying menstrual psychosis cases in health records
• Brand et al. 2024, menopausal hormone therapy and relapse
• Estrogen and psychosis: review and future directions
• Midlife psychosis risk and perimenopausal research gaps
• Practical methods for menstrual-cycle research